The diagnostic usefulness of fasting total serum bile acids (SBNF) in the detection of liver diseases and assessment of different aspects of hepatic function alteration was evaluated in 61 healthy subjects and 186 patients with liver disease. The value of SBNF was compared with other routine tests. In 49 healthy subjects and 92 patients, serum bile acids were also measured after the im administration of Ceruletide as a cholecystokinetic agent (SBNC).
Elevations of serum bile acid (SBA) concentrations have been found in different hepatobiliary disorders': 2 and the determination of total and individual SBA has been proposed as a valuable test for liver diseases diagnosis.P? The determination of SBA was also claimed to be more specific than the conventional laboratory tests'': 7 and as sensitive as the BSP retention test and the indocyanine green clearance test for the detection of liver diseases.v 8 The measurement of SBA levels after gall-bladder contraction has been reported also to further increase diagnostic sensitivity of the test, I. 3. 9. 10 mainly for the detection of anicteric liver diseases and 'minimal' liver alterations. 11. 12 The initial report of Korman, Hofmann and Summerskill':' found that cholic acid determina-Correspondence: A Cavanna, MD, Patologia Medica A, Universita degli Studi, Via Genova, 3, 10126 Torino Italy.
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tion could provide a more sensitive index of the hepatic involvement in chronic active hepatitis than other conventional laboratory tests. Since then SBA concentrations have been reported'P: 14, 15 to reflect liver morphological alterations and to correlate with the seriousness of the hepatic impairment.
The actual role of SBA determination in clinical practice is still debated.P " Questions arise not only because of some contradicting results'': 9. Ill. 14. 19, 20 but also from a poor understanding of the pathophysiological meaning of altered SBA levels in liver diseases. 21 -23 We evaluated the diagnostic utility of the SBA test for both the detection of the disease and the assessment of the liver function impairment. For this latter purpose SBA concentrations are compared to a detailed clinical assessment of liver patients, concerning three main aspects of the hepatic alteration: impaired biosynthesis, cholestasis and hepatocellular necrosis.
Materials and methods

I I I I
Each subject underwent a careful clinical examination and a detailed laboratory investigation. Experimental evaluations were performed independently of the routine diagnostic procedure.
A venous blood sample was taken after an SUBJECTS Two hundred and forty-seven subjects (155 males and 92 females), aged 18-81 years, were examined consecutively in a 6-month period. The sample (Table 1) overnight fast for the determination of fasting serum bile acids (SBNF) and of a large set of liver tests (about 30). Tests included aspartate aminotransferase (AST) , alanine aminotransferase (ALT), y-glutamyl transferase (y-GT), alkaline phosphatase (APh), direct-reacting bilirubin (d-BIL) and pseudocholinesterase (CRE).
In order to evaluate serum bile acids after gall-bladder contraction (SBNC), a second blood sample was taken also 60 min after the im injection of 200 ng/kg bw of Ceruletide (Laboratori Ricerca Farmitalia-Carlo Erba, Milano). This procedure was applied to 49 control subjects and 92 patients (Table 1) , who gave their informed consent; patients affected by acute viral hepatitis and severely ill patients were excluded for ethical reasons.
ANALYTICAL METHODS
Total serum bile acids were determined by an enzymatic-fluorimetric procedure (Stereognost-3a-Flu, Nyegaard & Co, Oslo, Norway). The other laboratory tests were performed by the usual standard procedures: AST, ALT, y-GT, APh and d.BIL. were determined with commercial kits purchased from Boehringer Biochemia, Milan, Italy; CRE was determined with the kit from Merck, Darmstadt, West Germany.
STATISTICAL METHODS
General results SBNF and SBNC concentrations are expressed as mean values ±SD. The Wilcoxon rank sum test for two independent samples/" was used to evaluate the significance of the differences of SBA levels among the diagnostic groups and within the functional classes. The sign test 25 was used to determine the significance of the difference between SBNF and the corresponding SBNC concentrations. P values less than 0·05 were considered to be significant.
DIAGNOSTIC EFFICACY FOR THE
DETECTION OF LIVER DISEASES
The diagnostic efficacy of the tests was evaluated by assessing the specificity, the sensitivity and the values of both the positive and the negative prediction, with their respective 95% confidence intervals.P'
To this extent a reference classification based on the conclusive clinical diagnosis was used. The subjects were grouped into two classes, an 'absent disease' class, including control subjects only, and a 'present disease' class, including all patients except those belonging to the 'undefined liver diseases' group (13 elements), whose definite diagnosis did not exist. Test values were considered 'positive' when they exceeded the reference values. Normal reference limits of our laboratory are: SBAIF = 9 umol/L; SBNC = 15 urnol/L; AST: males = 18 IU, females = 15 IU; ALT = males = 22 IU, females = 17 IV; y-GT: males = 28 IU, females = 18 IU, APh = 170 IU; d-BIL = 0·35 mgldL; CRE = 3600 IU.
Separate statistical evaluations were carried out for SBNF, SBNC and the combined tests SBNF -l-C, In the latter case a 'parallel' procedure was adopted and a result was considered 'positive' when' at least one of the two test values was 'positive'.
The predictive values were computed at the disease prevalence of the studied sample (0,74 for SBNF and the other routine tests and 0·65 for SBNC and SBNF+C). Test parameters were compared'? as follows: the receiver operating characteristic (ROC) curves of the tests were first computed, with their 95% confidence intervals, for an overall comparison of specificities and sensitivities over a wide range of different cut-off values. The z statistic for proportions/" was then used to make point comparisons and to assess the statistical significance of their differences. Sensitivities and specificities of routine tests were compared, respectively, with the SBAIF sensitivity and specificity values given by the cut-off level of 9 umol/L (sensitivities were compared where the tests gave equal specificities and specificities were compared where the tests sensitivities were equal); predictive values were compared at the sample prevalence.
Diagnostic efficacy for the assessment of liver function impairment
Six groups of four experienced physicians (from the staffs of the five medical divisions and the hospital laboratory department which participated in this study), not being aware of the conclusive clinical diagnosis, separately classified all the subjects entering the study according to the severity of the liver function impairment. 29 The clinical evaluations were made on the basis of all clinical and laboratory data, and separately concerned three different aspects of the liver alteration: impaired biosynthesis, cholestasis and hepatocellular necrosis. For each type of alteration, four different classes corresponding to four degrees of progressive severity were considered: 0 = null; 1 = mild; 2 = medium; 3 = advanced. For each type of alteration each subject received, as a definite score, the score given by the majority of the six groups of examiners, or the higher score between two different scores in case of doubt. Three conclusive reference classifications of all subjects were then obtained. The agreement reached among the six groups of physicians in the evaluation of impaired biosynthesis, cholestasis and hepatocellular necrosis was 67,5%, 78% and 89·5%, respectively.
These reference classifications were then used to check the diagnostic efficacy of individual tests: SBAIF was tested in the assessment of all the three function alterations, whereas CHE, d.BIL and ALT were selected, for comparison, in the assessment of reduced biosynthesis, cholestasis and hepatocellular necrosis respectively.
The diagnostic efficacy of each test was separately evaluated by means of a statistical classification procedure based on Bayes rule, allocating each subject in one of the four severity classes according to the test value. Allocations were performed with the computer program Alloc.i" The probability-density functions required to compute the a-posteriori probability were Parzen estimates" (ie, no apriori assumption about normality or any other shape of the variable distribution was made). Misclassification errors (percentage of subjects allocated to a class different from the reference class) were estimated by the leave-one-out method.F This technique provides a reliable estimate of error rates when the sample is small and cannot be split into a training and test sample.
For each single test the mean misclassification error (ie, the weighted average of the four misclassification errors, with weights given by the number of subjects in each class) was computed also. Table 1 shows SBA concentrations (mean ±SD and ranges) in the fasting state (SBAlF) and after Ceruletide administration (SBAle) in the diagnostic groups of subjects. In the control group, no differences in SBAIF and SBAIC levels are observed between males and females. The percentage increase of SBA concentrations after Ceruletide is significant in all the diagnos- <0·001 tic groups, ranging from 73·6±71·2% (mean ±SD) in controls to 161·8±156·8% (mean ±SD) in compensated cirrhosis. Patients affected by alcoholic hepatitis and chronic persistent hepatitis have SBNF and SBNC concentrations significantly lower (P<0·05) than those observed in chronic active hepatitis. The differences in SBA levels between compensated cirrhosis, ascitic cirrhosis and chronic active hepatitis are not significant. Figure 1 shows SBNF concentrations (mean ±SD) in the four classes of damage for the three considered types of liver alteration. The highest values are observed in the presence of a severe cholestatis and hepatocellular necrosis. Table 2 shows the results concerning the evaluation of the diagnostic efficacy of SBNF and the routine liver tests in the sample. Specificity, sensitivity and predictive values are reported with their 95% confidence intervals.
Results
GENERAL RESULTS
DIAGNOSTIC EFFICACY FOR THE
DETECTION OF LIVER DISEASES
As compared to the other tests, SBNF gives a high specificity and an intermediate sensitivity, false-negative results being present in all groups of patients, except for obstructive jaundice.
The positive predictive accuracy is significantly better for SBNF than for AST and y-GT, whereas AST gives an accuracy significantly higher than SBNF for the negative prediction.
The ROC curves of AST, ALT, y-GT and SBNF are plotted in Fig. 2 for an overall comparison of their performances. Over the whole range of different cut-off values, except in the high specificity region, AST, ALT and y-GT perform better than SBNF, ie, at any given sensitivity they present a better specificity and at any given specificity they present a higher sensitivity, though their confidence intervals widely overlap. In the high specificity region they cross the SBNF curve and at the SBNF specificity level (0'97) y-GT is significantly less sensitive. The ROC curves of APh, CHE and d-BIL, not reported in the figure for the sake of simplicity, lie on the right side of the SBNF curve. At its specificity level SBNF is significantly more sensitive than these three tests.
No significant difference in specificity between SBNF and all the other tests is present at the SBNF sensitivity level (0·70).
The results of the study of diagnostic efficacy with SBNC and the combined tests SBNF+C are reported in Table 3 . Since the sample composition has changed (lower disease prevalence and no patient with acute viral hepatitis included), the results of SBNF diagnostic efficacy, reported for comparison, are slightly different. SBNC and SBNF+C give no false negative result only in ascitic cirrhosis, primary biliary cirrhosis and obstructive jaundice.
The ROC curves (unreported data) of the three tests overlap widely and the differences among their specificities, sensitivities and predictive values are not significant.
DIAGNOSTIC EFFICACY FOR THE
ASSESSMENT OF LIVER FUNCTION
IMPAIRMENT
The allocation matrices reported in Table 4 show the efficiency of SBNF, CHE, d.BIL and ALT in identifying the severity or degree of the different liver dysfunctions. As concerns SBAIF, the mean misclassification errors are quite high and similar for all the three types of functional alteration. The detailed examination of the allocation matrices indicates, however, that 'severe' misclassification errors (ie allocation of similar to the corresponding one obtained with SBNF; CHE however shows few 'severe' misallocation errors in the evaluation of the biosynthetic alteration when compared to SBNF.
Discussion
GENERAL RESULTS
Serum bile acid fasting levels are higher than normal in patients with liver disease and the highest values are observed in patients affected by acute viral hepatitis and obstructive jaundice. In patients affected by alcoholic hepatitis and chronic persistent hepatitis, however, SBNF levels are not significantly different with respect to control subjects. Among the different chronic liver disease groups, SBNF concentrations increase from chronic-persistent to chronic-active hepatitis and from these to compensated and ascitic cirrhosis. Individual results are widely scattered, however, and a considerable overlap is observed among diagnostic groups so that SBNF levels prove to be of only limited value in discriminating the different chronic liver diseases. The administration of Ceruletide as a cholecystokynetic agent was preferred in this study to a standard meal in order to obtain a better standardisation of the test. In both control subjects and patients Ceruletide administration determines a significant increase of SBA concentrations. With respect to the SBNF test, however, no substantial improvement in discriminating among the different diagnostic groups is obtained with SBNC determination.
DIAGNOSTIC EFFICACY FOR THE DETECTION OF LIVER DISEASES
The SBNF test was found to have a high specificity but a somewhat lower sensitivity. The examination of diagnostic errors of the SBNF test shows that 'false-negative' results, although mostly occurring in 'minor' liver diseases (alcoholic hepatitis and chronic persistent hepatitis), are found also in patients affected by more severe liver diseases, such as cirrhosis and chronic-active hepatitis.
Higher sensitivities are obtained with AST, ALT and y-GT, and these tests show a still lower number of 'false-negative' errors in all groups of diseases (unreported data).
A more general comparison of the discriminatory power of the tests can be visualised in Fig. 2 where the ROC curves are plotted. The
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ROC curve, showing the inverse relationship of specificity and sensitivity characteristic of each test, can describe a test performance better than the raw estimate of specificity and sensitivity at a single cut-off value.
The comparison of the ROC curves shows that AST and AL T, but not y-GT, are better discriminators than SBNF, though no statistically significant difference is present at the SBNF specificity and sensitivity levels, 0·97 and 0·70 respectively. On the contrary, a poorer performance characterises APh, CHE and d-BIL.
When SBA levels are determined after Ceruletide administration (SBNC) 'falsenegative' results are reduced slightly with respect to the fasting state and a further small increase in sensitivity and negative predictive value is obtainable with the combined tests SBNF+C. These gains in test performance are counter-balanced by a moderate drop in the test specificity and positive prediction. Moreover test comparisons show that the discriminatory power and the predictive values are not significantly different among SBNF, SBNC and SBNF+C, so that the determination of SBA concentrations after Ceruletide administration does not represent an effective diagnostic advantage with respect to the simple evaluation of the fasting concentrations.
In the sample studied (disease preva-lence=0'74) the SBNF test presents a much higher value for the positive than for the negative prediction: a 0·98 probability of hepatobiliary disease and a 0·54 probability of health are given by a SBNF concentration exceeding the normal limit or in the normal range, respectively.
The high specificity and accuracy in the positive prediction observed could suggest that the SBNF test might be of value particularly in 'ruling in' liver diseases.i" any abnormal result supporting highly the probability of the presence of an hepatobiliary disease. These conclusions however can only be applied to samples with a high disease prevalence. The predictive values of any diagnostic test markedly change when the disease prevalence lowera.P: 34 With a disease prevalence of 0·01, which still exceeds the actual prevalence of liver disease in the general population, the diagnostic value of the SBNF test, computed assuming the same specificity and sensitivity found in the examined sample, would be strikingly different: 0·166 for the positive and 0·997 for the negative prediction. At this prevalence no statistically signifi-cant difference can be observed any more between the predictive values of SBAIF and of all the other examined tests.
DIAGNOSTIC EFFICACY FOR THE
ASSESSMENT OF LIVER FUNCTION
IMPAIRMENT
In this study the efficacy of the SBA test in the assessment of different types of the liver function impairment is tested, thus allowing a more comprehensive evaluation of the diagnostic usefulness of this 'new' test in clinical practice. The routine liver tests commonly employed in hepatobiliary diagnosis in fact are not only regarded as indicating the presence of the disease state, but are also extensively utilised by the physicians as measures of the severity of the liver alterations, so that their determination implies to some extent a functional evaluation.
Our results show that serum bile acid fasting concentrations reflect roughly the degree of hepatic impairment, as they progressively increase from class 0 to class 3 for each considered aspect of the liver function alteration. The statistical evalution of the test discriminatory power, giving a quite high rate of misclassification errors indicates, however, that the diagnostic usefulness of the SBAIF test in the assessment of the severity of liver alterations is questionable.
Somewhat better results are obtained when the SBAIF test is applied in the evaluation of cholestasis. With this test the error rate in classifying subjects belonging to the extreme classes of damage (classes 2 and 3) is rather low. The high error rate in these subjects with mild cholestasis (class 1), who were incorrectly classified as normal, indicates the poor diagnostic sensitivity of the test.
As compared with SBAlF, ALT gives much more satisfactory results in the assessment of necrosis and CHE is more reliable in evaluating impaired biosynthesis, showing a lower rate of 'severe' misallocation errors and a higher efficiency in the assessment of the 'medium' and 'advanced' alterations. On the contrary, similar results are obtained with d-BIL and SBAIF in the evaluation of cholestasis.
In conclusion, our data show that:
(1) SBA determination represents a highly specific but less sensitive test for the detection of liver diseases, particularly alcoholic hepatitis and chronic persistent hepatitis;
(2) the diagnostic efficacy of the test is not increased by SBA determination after gallbladder contraction;
(3) SBA levels are not reliable in the assessment of the severity of the liver function alterations;
(4) the SBA test does not seem to provide any effective diagnostic advantage with respect to the other routine liver tests.
